http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104491242-B
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4866 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-41 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-62 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-888 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2059 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-539 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-62 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-888 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 |
filingDate | 2014-11-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2018-10-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2018-10-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-104491242-B |
titleOfInvention | A kind of pharmaceutical composition and its preparation method and application for treating cognition dysfunction |
abstract | The invention belongs to technical field of traditional Chinese medicines, specifically provide a kind of pharmaceutical composition for treating cognition dysfunction, its bulk pharmaceutical chemicals is formed by red stilbene, radix scutellariae, rhodiola root, grass-leaved sweetflag and earthworm compatibility, the ranging from red stilbene 10-100 parts by weight of its weight proportion, radix scutellariae 8-80 parts by weight, rhodiola root 5-60 parts by weight, grass-leaved sweetflag 5-60 parts by weight, earthworm 3-50 parts by weight.The present invention also provides the preparation method of the pharmaceutical composition and particular uses.Pharmaceutical composition of the present invention is the experiment proved that the ability of learning and memory of vascular dementia rats model can be significantly improved, reduce the activity of MDA and MAO in hippocampal tissue and serum, the mouse pia mater local microcirculation obstacle caused by norepinephrine can be improved in various degree, make arteriole blood vessel dilatation, blood flow is speeded, the experimental results showed that pharmaceutical composition of the present invention has apparent therapeutic effect to vascular dementia. |
priorityDate | 2014-11-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 78.